About Matthew Robbins
Form D filings for Bright Peak Therapeutics in 2024 list Matthew Robbins as executive officer.
Matthew Robbins first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Robbins in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Robbins works with at each company, as listed on that company's latest Form D.
Bright Peak Therapeutics, Inc. · Form D, Jun 11, 2024
BK
Bertolt Kreft
Executive officer
LS
Laura Shawver
Director
TW
Tom Woiwode
Director
VP
Vijaya Pattabiraman
Executive officer
LG
Leena Gandhi
Director
AX
Asish Xavier
Director
CS
Christine Siu
Director
FW
Fredrik Wiklund
Chief Executive Officer and director
EM
Emily Minkow
Director
JW
Jon Wigginton
Executive officer
JC
Jacob Chacko
Director